Status:
UNKNOWN
A Comparative Trial of a Minimal-invasive Technique Versus Open Arthrodesis in the Treatment of Midfoot Arthritis
Lead Sponsor:
Kantonsspital Baden
Conditions:
Osteoarthritis
Foot
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Group A: Patients suffering from midfoot arthritis after failed prior conservative therapy who undergo a reverse distal metatarsal minimal-invasive osteotomy Group B: Patients suffering from midfoot a...
Detailed Description
Midfoot arthritis is a common condition leading to disabling chronic foot pain that affects activities of daily living. The causes can be primary osteoarthritis (OA), inflammatory or post-traumatic. W...
Eligibility Criteria
Inclusion
- Patients older than 18 years
- Midfoot arthritis of lesser TMTJ (second, third, rarely fourth and fifth) with ongoing disabling pain
- Able to give informed consent as documented by signature
- failed conservative treatment for a period of at least 3 months (CSI injections and/or orthotic devices)
Exclusion
- Concomitant fusion of 1st TMTJ
- Patients younger than 18 years
- Contraindication to undergo surgery or general anaesthesia
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
- pregnancy
Key Trial Info
Start Date :
May 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04894578
Start Date
May 14 2021
End Date
December 31 2024
Last Update
May 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Baden
Baden, Canton of Aargau, Switzerland, 5400